appetite auppresant (Major drug group)

January 2002
Royal Society of Medicine: Medicines;2002, p84
Reference Entry
The article presents information on appetite auppresants. These drugs are used to treat obesity. The first of the drugs acting on the brain, and a number of such drugs that have been used are related and have actions similar to the stimulant amfetamine. The second type of appetite suppressants work by bulking out the food eaten so that the body feels it has actually taken more than it has.


Related Articles

  • METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Spring2013, Vol. 7 Issue 1, p127 

    The article offers information on several drug prescriptions used for the treatment of metabolic disorders particularly obesity. It says that Adipex-P from Teva is used for short-term monotheraphy as adjunct in management of exogenous obesity. It states that Alli from GlaxoSmithKline is used to...

  • Capítulo1: Metabolismo energético. Krupa Das, Sai; B. Roberts, Susan // Conocimientos Actuales sobre Nutrición;2003, p3 

    The energetic equilibrium is adjusted by particularly sensitive mechanisms which have been identified during the present investigations. The disorders in the energetic equilibrium emerge from the genetic and environmental causes and explain many of the current common health problems in the...

  • The Global Epidemic of Obesity: Why Global Approaches Won't Work. Miller, Wayne C. // Healthy Weight Journal;Nov/Dec2001, Vol. 15 Issue 6, p81 

    Editorial. Explores the global epidemic of obesity. Efforts to prevent overweight and obesity; Assumptions underlying obesity treatment paradigms; Efficiency of obesity treatment programs.

  • Obesity Treatment and Trends, Today and Tomorrow. Harris, Michael // BioWorld International;5/26/2010, Vol. 15 Issue 21, Special section p1 

    The article discusses various issues concerning obesity. It reveals that obesity is globally increasing but the drug and medical technology markets has become reliant on developed products for major illnesses. Surgery, according to the author, is the treatment of choice for obesity. They...

  • New Targets for Obesity Pharmacotherapy. Aronne, L. J.; Thornton-Jones, Z. D. // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p748 

    An understanding of the mechanisms that regulate energy homeostasis is essential for understanding novel obesity therapies. The status of energy reserves is communicated to the brain by adiposity and satiety signals. These signals modify either anabolic or catabolic pathways and, consequently,...

  • Rimonabant: A novel selective cannabinoid-1 receptor antagonist for treatment of obesity. Patel, Priti N.; Pathak, Rolee // American Journal of Health-System Pharmacy;3/1/2007, Vol. 64 Issue 5, p481 

    Purpose. The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, and dosage and administration of rimonabant in the treatment of obesity and related metabolic factors are reviewed. Summary. Discovery of the cannabinoid receptors has led to the development of rimonabant,...

  • Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai // Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107 

    Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue...

  • NUTRITION.  // Monthly Prescribing Reference;Jul2011, Vol. 27 Issue 7, p248 

    A chapter of the book "Monthly Prescribing Reference" is presented. It presents the drugs used for treating different types of nutrition disorders, including PamLab LLC's Cerofolin for treating hyperhomocysteinemia, Biocodex SA's Florastor to promote intestinal health and maintain normal bowel...

  • Obesity solutions? Edell, Dennis // CMAJ: Canadian Medical Association Journal;3/17/2015, Vol. 187 Issue 5, p358 

    A letter to the editor is presented in response to the editorial "A political prescription is needed to treat obesity," by J. Fletcher and K. Patrick in a 2014 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics